Breast fibroadenoma: Mapping of pathophysiologic features with three- time-point, contrast-enhanced MR imaging - Pilot study

Radiology

Volumn 210, Issue 1, 1999, Pages 233-240

  Weinstein, Daphna ^a,d   Strano, Shalom ^b,e   Cohen, Patricia ^c   Fields, Scott ^c   Gomori, J Moshe ^c   Degani, Hadassa ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b KAPLAN HOSPITAL   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d ASSAF HAROFEH MEDICAL CENTER   (Israel)

^e Rachel Nash Compreh Breast Center   (Israel)

Author keywords

Breast neoplasms, MR; Magnetic resonance (MR), tissue characterization

Indexed keywords

ADULT; ARTICLE; BLOOD VESSEL PERMEABILITY; BREAST FIBROADENOMA; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; EXTRACELLULAR SPACE; FEMALE; HUMAN; HUMAN TISSUE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0032955577     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.210.1.r99ja18233     Document Type: Article

References (42)

1. Degani H, Gusis V, Weinstein D, Fields S, Strano S. Mapping pathophysiological features of breast tumors by MRI at high spatial resolution. Nature Med 1997; 3:780-782.
2. Turkat TJ, Klein BD, Polan RL, Richman RH. Dynamic MR mammography: a technique for potentially reducing the biopsy rate for benign breast disease. JMRI 1994; 4:563-568.
3. Flinkiger FW, Allison JK, Sherry RM, Wright JC. Differentiation of benign from malignant breast masses by time-intensity valuation of contrast enhanced MRI. J Magn Reson Med 1993; 11:617-620.
4. Fobben ES, Rubin CZ, Kalisher L, Dembner AG, Seltzer MH, Santoro EJ. Breast MR imaging with commercially available techniques: radiologic-pathologic correlation. Radiology 1995; 196:143-152.
5. Cortan RS, Kumar V, Robbins SL. Robbins pathologic basis of disease. 4th ed. Edinburgh, UK: Livingstone, 1989; 1189-1190.
6. Ahmed A. Diagnostic breast pathology: a text and colour atlas. Edinburgh, UK: Livingstone, 1992; 72-76.
7. Bland KI, Copeland EM. The breast: comprehensive management of benign and malignant diseases. Philadelphia, Pa: Saunders, 1991.
8. Obermair A, Czerwenka K, Kurz C, Kaider A, Sevelda P. Tumoral vascular density in breast tumors and their effect on recurrence-free survival. Chirurg 1994; 65:611-615.
9. Holcombe C, Pugh N, Lyons K, Douglas-Jones A, Mansel RE, Horgan K. Blood flow in breast cancer and fibroadenoma estimated by color Doppler ultrasonography. Br J Surg 1995; 82:787-788.
10. Rigauts H, Casselman J, Steyaert L, Devlies F, Pattyn G. Contribution of MRI and color Doppler sonography in breast cancer diagnosis. J Belge Radiol 1993; 76:226-231.
11. Kaiser WA. Dynamic magnetic resonance breast imaging using a double breast coil: a step toward routine examination of the breast. Front Eur Radiol 1990; 7:39-68.
12. Harms SE, Flamig DP. MR imaging of the breast. JMRI 1993; 3:277-283.
13. Stomper PC, Herman S, Klippenstein DL, et al. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 1995; 197: 387-395.
14. Heywang-Kobrunner SH, Haustein J, Paul C, et al. Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine. Radiology 1994; 191:639-646.
15. Terao E, Takeuchi H, Iwamura A, Murakami Y, Harada J, Tada S. Ability of subtraction and dynamic MR imaging to detect breast tumors: comparison with ultrasonography and mammography. Nippon Igaku Hoshasen Gakkai Zasshi 1994; 54:950-957.
16. Gribbestad IS, Nilsen G, Fjosne HE, Kvinnsland S, Haugen OA, Rinck PA. Comparative signal intensity measurements in dynamic gadolinium-enhanced MR mammography. JMRI 1994; 4:477-480.
17. Orel SG, Schnall MD, Livolsi VA, Troupin RH. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 1994; 190:485-493.
18. Hochman MG, Orel SG, Powell CM, et al. Fibroadenomas: MR imaging appearances with radiologic-histopathologic correlation. Radiology 1997; 204:123-129.
19. Kaiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Radiology 1989; 170: 681-686.
20. Hoffmann U, Brix G, Knopp MV, Heb T, Lorenz WJ. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med 1995; 33:506-514.
21. Frouge C, Guinebretiere JM, Contesso G, Paola RD, Blery M. Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis. Invest Radiol 1994; 12:1043-1049.
22. Hulka CA, Smith BL, Sgroi DC, et al. Benign and malignant breast lesions: differentiation with echo-planar MR imaging. Radiology 1995; 197:33-38.
23. Kennedy SD, Szczepaniak LS, Gibson SL, Hilf R, Foster TH, Bryant RG. Quantitative MRI of Gd-DTPA uptake in tumors: response to photodynamic therapy. Magn Reson Med 1994; 31:292-301.
24. Perman WH, Heiberg EM, Grunz J, Herrmann VM, Janney CG, A fast 3D-imaging technique for performing dynamic Gd-enhanced MRI of breast lesions. Magn Reson Imaging 1994; 12:545-551.
25. Tofts PS, Berkowitz B, Schnall MD. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med 1995; 33:564-568.
26. Knopp MV, Heb T, Hoffmann U, et al. Assessment of different quantification techniques for MR-mammography (abstr). In: Proceedings of the Third Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 1995; 1599.
27. Hylton N, Frankel SD, Esserman LJ, Moore K, Sickles E. High resolution 3D maps of contrast enhancement patterns in breast tumors (abstr). In: Proceedings of the Third Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 1995; 439.
28. Buckley DL, Mussurakis S, Blackband SJ, Drew PJ, Horsman A. Dynamic MR mammography: a comparison of two pharmacokinetic modeling techniques (abstr). In: Proceedings of the Third Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 1995.
29. Kelcz F, Santyr GE, Cron GO. Application of a quantitative model to differentiate benign from malignant breast lesions detected by dynamic, Gd-enhanced MRI. Magn Reson Med 1996; 6:743-752.
30. Mussurakis S, Buckley DL, Bowsley SJ, et al. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma. Invest Radiol 1995; 30:650-662.
31. den Boer JA, Hoenderop RKKM, Smink J, et al. Pharmacokinetic analysis of Gd-DTPA enhancement in dynamic three dimensional MRI of breast lesions. J Magn Reson Med 1997; 7:702-715.
32. Nunes LW, Schnall MD, Orel SG, et al. Breast MR imaging: interpretation model. Radiology 1997; 202:833-841.
33. Nunes LW, Scnall MD, Siegelman ES, et al. Diagnostic performance characteristics of architectural features revealed by high spatial resolution MR imaging of the breast. AJR 1997; 169:409-415.
34. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. I. Fundamental concepts. Magn Reson Med 1991; 17:357-367.
35. Degani H, Fields S, Catane R, Gomori JM, Peretz T, Libove A. Evaluation of breast cancer therapy with contrast enhanced MRI at high spatial resolution. JMRI 1994; 4:116.
36. Stelling CB, Powell DE, Mattingly SS. Fibroadenomas: histopathologic and MR imaging features. Radiology 1987; 162: 399-407.
37. Weidmann HJ, Laniado M, Mutzel W. Pharmacokinetic of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 1984; 16:167-172.
38. Poon CS, Bronskill MJ, Henkelman RM, Boyd NF. Quantitative magnetic resonance imaging parameters and their relationship to mammographic pattern. J Natl Cancer Inst 1992; 84:777-781.
39. Laufer RB. Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem Rev 1987; 87:901-927.
40. Stack JP, Redmond OM, Codd MB, Dervan PA, Ennis JT. Breast disease tissue characterization with Gd-DTPA enhancement profiles. Radiology 1990; 174:491-494.
41. Merchant TE, de Graf PW, Neiwenhuizen WEA, et al. Fibroadenoma of the breast: in vivo magnetic resonance characterization. EurJ Radiol 1991; 13:91-95.
42. Kelcz F, Santyr GE, Cron GO. Incorporation of wash-in and washout criteria for improvement of specificity in dynamic gadolinium-enhanced MRI of breast lesions (abstr). In: Proceedings of Third Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 1995; 435.